Which has the lower trailing P/E, CME or NBIS?

CME has the lower trailing P/E: CME trades at 21.66 and NBIS at 62.63. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CME or NBIS?

Over the past five years, CME grew revenue faster — CME at a 7.99% CAGR versus NBIS at -23.11%.

Does CME or NBIS pay a bigger dividend?

CME pays a dividend (1.49% yield), while NBIS has no payments in the available dividend history.

Is CME or NBIS more profitable?

NBIS runs the higher net margin — CME at 63.08% versus NBIS at 95.27%.

CME Group Inc. (CME) vs Nebius Group N.V. (NBIS)

A side-by-side comparison of CME Group Inc. and Nebius Group N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Different business models: CME is classified in Financial Services; NBIS is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

CME

CME Group Inc.

$94.21B

$260.00Financial ServicesDelayed quote: Jul 28, 2026, 4:00 PM EDT

NBIS

Nebius Group N.V.

$40.73B

$169.69TechnologyDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — CME vs NBIS

growth of $100 · dividends reinvested · last 2y

CME +21.7%NBIS +795.7%NBIS compounded faster

Log scale — wide-divergence pair

CME NBIS

CME vs NBIS: by the numbers

•CME is the larger company ($94.21B vs $40.73B market cap).
•CME trades at the lower trailing earnings multiple (21.66 vs 62.63 P/E), one valuation lens rather than an overall verdict.
•NBIS converts more revenue to profit (95.27% vs 63.08% net margin).
•CME grew revenue faster over the past five years (7.99% vs -23.11% CAGR).
•CME pays a dividend (1.49% yield), while NBIS has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CME	NBIS
P/E ratio	21.66	62.63
Forward P/E	20.84	N/A
P/S ratio	13.66	66.12
P/B ratio	3.49	8.02
PEG ratio	1.59	N/A

Profitability

Metric	CME	NBIS
Gross margin	81.89%	68.63%
Operating margin	65.10%	-112.53%
Net margin	63.08%	95.27%
ROE	16.11%	11.55%
ROIC	1.62%	-4.75%

Dividends

Metric	CME	NBIS
Dividend yield	1.49%	N/A
Payout ratio	33.99%	N/A

Growth (annualized)

Metric	CME	NBIS
Revenue CAGR (5Y)	7.99%	-23.11%
EPS CAGR (5Y)	13.72%	-35.43%
Total return CAGR (5Y)	8.15%	N/A

Frequently asked

Which has the lower trailing P/E, CME or NBIS?: CME has the lower trailing P/E: CME trades at 21.66 and NBIS at 62.63. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CME or NBIS?: Over the past five years, CME grew revenue faster — CME at a 7.99% CAGR versus NBIS at -23.11%.
Does CME or NBIS pay a bigger dividend?: CME pays a dividend (1.49% yield), while NBIS has no payments in the available dividend history.
Is CME or NBIS more profitable?: NBIS runs the higher net margin — CME at 63.08% versus NBIS at 95.27%.

Go deeper

Full CME analysis Full NBIS analysis Interactive comparison tool

Dig into the metrics

CME P/E ratio Nebius P/E ratio CME dividend yield Nebius dividend yield CME ROE Nebius ROE CME operating margin Nebius operating margin CME revenue growth Nebius revenue growth CME free cash flow Nebius free cash flow

CME & Nebius appear in these rankings

Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.